Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

BUYINS.NET: MT, DMC, NG, TTP, BPAX, HTLF Have Been Removed From Naked Short List Today

Tue. August 26, 2008; Posted: 08:59 AM
Stocks RSS
Aug 26, 2008 (M2 PRESSWIRE via COMTEX) -- TTP | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: Arcelor Mittal (NYSE: MT), Document Security Systems Inc (AMEX: DMC), NovaGold Resources Inc (AMEX: NG), Titan Pharmaceuticals Inc (AMEX: TTP), Biosante Pharmaceuticals Inc. (NASDAQ: BPAX), Heartland Financial USA Inc. (NASDAQ: HTLF). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

Arcelor Mittal (NYSE: MT | Quote | Chart | News | PowerRating) engages in the production and marketing of steel worldwide. The company produces a range of finished and semi-finished carbon steel products. It primarily offers flat products, including sheet and plate; long products, including bars, rods, and structural shapes; and stainless steel products. The company serves various customer markets, including automotive, construction, household appliances, and packaging with sizeable captive supplies of raw materials and distribution networks. As of December 31, 2007, it had an annual production capacity of approximately 130 million tones of crude steel. It was formerly known as Mittal Steel Company N.V. The company was founded in 1989 and is headquartered in Luxembourg, Luxembourg. With 1.38 billion shares outstanding and 4.91 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of MT.

Document Security Systems Inc (AMEX: DMC | Quote | Chart | News | PowerRating) markets and sells products to protect information from unauthorized scanning, copying, and digital imaging. It licenses, manufactures, and sells document security technologies, including digital security print solutions and secure printed products. The company's document security solutions are used by end-users that require anti-counterfeiting, brand protection and liability, fraud and identity theft, and authentication features in a range of printed materials, such as documents, passports, vital records, driver's licenses, birth certificates, receipts, manuals, identification materials, entertainment tickets, coupons, and parts tracking forms, as well as in pharmaceutical and consumer goods product packaging. Its products include AuthentiGuard Security Paper that reveals hidden warning words, logos, or images, when the paper is faxed, copied, and scanned; and custom-designed security papers for high-end security solutions with special non-public authentication systems. The company also owns and operates Legalstore.com that sells legal supplies and documents, including security paper and products for the users of legal documents and supplies in the legal, medical, and educational fields. The company markets its anti-counterfeiting products and technologies under the AuthentiGuard On-Demand, AuthentiGuard Laser Moir?, AuthentiGuard Prism, AuthentiGuard Pantograph 4000, AuthentiGuard Survivor 21, AuthentiGuard Obscurascan, AuthentiGuard Block-Out, AuthentiGuard MicroPerf, AuthentiGuard Phantom, and AuthentiGuard VeriGlow trade names. Document Security Systems serves federal, state, and local governments; financial institutions; and law enforcement agencies, as well as high technology and consumer goods, entertainment and gaming, academic/higher education, healthcare/pharmaceutical, defense, and genuine parts industries. The company, formerly known as New Sky Communications, Inc., was founded in 1984 and is based in Rochester, New York. With 14.17 million shares outstanding and 1.35 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of DMC. According to quarterly data provided by the SEC, there were still 10,359 shares of DMC that were failing-to-deliver as of September 27, 2007.

NovaGold Resources Inc (AMEX: NG | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the exploration and development of gold and copper properties in Alaska and British Columbia. The company owns interest in the Donlin Creek gold project in southwestern Alaska; a 50% interest in the Galore Creek copper-gold-silver project in British Columbia; and a 100% interest in the Grace claims located in northwestern British Columbia. It also owns a 100% interest in the Nome Gold property, which comprises Rock Creek, Big Hurrah, and Nome Gold projects located near the town of Nome, Alaska. In addition, NovaGold Resources has an option to acquire a 51% joint venture interest in the Ambler property with copper, zinc, gold, silver, and lead deposits located in northern Alaska. Further, the company operates hydroelectric projects located in British Columbia; and engages in the sale of sand, gravel, and land. The company was founded in 1984. It was formerly known as NovaCan Mining Resources (l985) Limited and changed its name to NovaGold Resources, Inc. in 1987. NovaGold Resources is based in Vancouver, Canada. With 105.16 million shares outstanding and 5.51 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of NG. According to quarterly data provided by the SEC, there were still 71,096 shares of NG that were failing-to-deliver as of September 28, 2007.

Titan Pharmaceuticals Inc (AMEX: TTP | Quote | Chart | News | PowerRating) together with its subsidiaries, operates as a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, and bone disease. Its products include Probuphine, a Phase III clinical trial product for the treatment of opioid addiction; Iloperidone for the treatment of schizophrenia and related psychotic disorders; and Spheramine, a Phase IIb clinical trial product for the treatment of advanced Parkinson's disease. The company also holds rights to diiodothyropropionic acid, a proprietary product for the treatment of cardiovascular disease; and gallium maltolate, an oral agent for the treatment of chronic bacterial infections, bone disease, and cancer. It has collaboration with Bayer Schering Pharma AG for the development of Spheramine to treat Parkinson's disease; and with Vanda Pharmaceuticals, Inc. to develop iloperidone for the treatment of schizophrenia and related psychotic disorders. The company was founded in 1992 and is based in South San Francisco, California. With 58.28 million shares outstanding and 1.07 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of TTP. According to quarterly data provided by the SEC, there were still 41,892 shares of TTP that were failing-to-deliver as of September 14, 2007.

Biosante Pharmaceuticals Inc. (NASDAQ: BPAX | Quote | Chart | News | PowerRating) a biopharmaceutical company, develops hormone therapy products to treat men and women. The company also engages in developing its proprietary calcium phosphate nanotechnology (CaP) primarily for aesthetic medicine, novel vaccines, and drug delivery. Its hormone therapy products include LibiGel, a transdermal testosterone gel, which is in Phase III development for the treatment of female sexual dysfunction; Elestrin, a transdermal estradiol gel for the treatment of menopausal symptoms in women; Bio-T-Gel, a transdermal testosterone gel for the treatment of hypogonadism or testosterone deficiency in men; and The Pill-Plus for the treatment of female sexual dysfunction in women using oral or transdermal contraceptives. The company's CaP products in development comprise BioLook, which is facial line filler in development using proprietary CaP technology in the area of aesthetic medicine; BioVant for the treatment of viral and bacterial infections and autoimmune diseases; BioOral, a delivery system using CaP technology for oral/buccal/intranasal administration of proteins and other therapies; and BioAir, a delivery system using CaP technology for inhalable versions of proteins and other therapies. The company was founded in 1996 and is based in Lincolnshire, Illinois. With 26.8 million shares outstanding and 687,000 shares declared short as of July 2008, there is no longer a failure to deliver in shares of BPAX. According to quarterly data provided by the SEC, there were still 93,419 shares of BPAX that were failing-to-deliver as of September 28, 2007.

Heartland Financial USA Inc. (NASDAQ: HTLF | Quote | Chart | News | PowerRating) together with subsidiaries, provides retail banking services in the United States. The company's deposit products include checking and demand deposit, negotiable order of withdrawal, savings, money market, individual retirement, and health savings accounts, as well as other time deposits and certificates of deposit. Its portfolio of loans includes commercial and industrial, agricultural, real estate mortgage, consumer, home equity, and lines of credit. Heartland also offers other products and services, including VISA debit cards, automated teller machines, online banking, safe deposit boxes, and trust services. In addition, it engages in investment brokerage activities. Further, Heartland offers vehicle, property and casualty, life, and disability insurance, as well as tax-free annuities. The company has strategic alliance with LPL Financial Institution Services to operate independent securities offices at its bank subsidiaries, as well as offers various investment services, such as mutual funds, annuities, retirement products, education savings products, brokerage services, employer sponsored plans, and insurance products. As of December 31, 2007, Heartland had 59 banking locations in Iowa, Illinois, Wisconsin, New Mexico, Arizona, Montana, and Colorado. The company was founded in 1993 and is headquartered in Dubuque, Iowa. With 16.31 million shares outstanding and 987,000 shares declared short as of July 2008, there is no longer a failure to deliver in shares of HTLF. According to quarterly data provided by the SEC, there were still 17,793 shares of HTLF that were failing-to-deliver as of September 27, 2007.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,100,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details for AMSAF click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [AMSAF]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.